nodes	percent_of_prediction	percent_of_DWPC	metapath
Fondaparinux sodium—F10—uterine cervix—uterine cancer	0.014	0.159	CbGeAlD
Fondaparinux sodium—F10—decidua—uterine cancer	0.0133	0.152	CbGeAlD
Fondaparinux sodium—F10—endometrium—uterine cancer	0.0126	0.144	CbGeAlD
Fondaparinux sodium—F10—mammalian vulva—uterine cancer	0.0122	0.139	CbGeAlD
Fondaparinux sodium—F10—female reproductive system—uterine cancer	0.0105	0.119	CbGeAlD
Fondaparinux sodium—F10—female gonad—uterine cancer	0.00953	0.109	CbGeAlD
Fondaparinux sodium—F10—vagina—uterine cancer	0.00947	0.108	CbGeAlD
Fondaparinux sodium—F10—lymph node—uterine cancer	0.00613	0.0698	CbGeAlD
Fondaparinux sodium—Immune system disorder—Etoposide—uterine cancer	0.000978	0.00107	CcSEcCtD
Fondaparinux sodium—Asthenia—Medroxyprogesterone Acetate—uterine cancer	0.000977	0.00107	CcSEcCtD
Fondaparinux sodium—Mediastinal disorder—Etoposide—uterine cancer	0.000975	0.00107	CcSEcCtD
Fondaparinux sodium—Sepsis—Doxorubicin—uterine cancer	0.00097	0.00106	CcSEcCtD
Fondaparinux sodium—Cardiac failure congestive—Epirubicin—uterine cancer	0.000967	0.00106	CcSEcCtD
Fondaparinux sodium—Pruritus—Medroxyprogesterone Acetate—uterine cancer	0.000964	0.00106	CcSEcCtD
Fondaparinux sodium—Vomiting—Progesterone—uterine cancer	0.000956	0.00105	CcSEcCtD
Fondaparinux sodium—Renal failure acute—Epirubicin—uterine cancer	0.00095	0.00104	CcSEcCtD
Fondaparinux sodium—Rash—Progesterone—uterine cancer	0.000948	0.00104	CcSEcCtD
Fondaparinux sodium—Dermatitis—Progesterone—uterine cancer	0.000947	0.00104	CcSEcCtD
Fondaparinux sodium—Phlebitis—Doxorubicin—uterine cancer	0.000942	0.00103	CcSEcCtD
Fondaparinux sodium—Headache—Progesterone—uterine cancer	0.000942	0.00103	CcSEcCtD
Fondaparinux sodium—Hot flush—Epirubicin—uterine cancer	0.000937	0.00103	CcSEcCtD
Fondaparinux sodium—Diarrhoea—Medroxyprogesterone Acetate—uterine cancer	0.000932	0.00102	CcSEcCtD
Fondaparinux sodium—Menopausal symptoms—Epirubicin—uterine cancer	0.000929	0.00102	CcSEcCtD
Fondaparinux sodium—Hepatic function abnormal—Doxorubicin—uterine cancer	0.000928	0.00102	CcSEcCtD
Fondaparinux sodium—Decreased appetite—Dactinomycin—uterine cancer	0.000924	0.00101	CcSEcCtD
Fondaparinux sodium—Dysgeusia—Etoposide—uterine cancer	0.000923	0.00101	CcSEcCtD
Fondaparinux sodium—Renal impairment—Epirubicin—uterine cancer	0.000921	0.00101	CcSEcCtD
Fondaparinux sodium—Dermatitis bullous—Epirubicin—uterine cancer	0.000918	0.00101	CcSEcCtD
Fondaparinux sodium—Fatigue—Dactinomycin—uterine cancer	0.000916	0.001	CcSEcCtD
Fondaparinux sodium—Back pain—Etoposide—uterine cancer	0.000911	0.000999	CcSEcCtD
Fondaparinux sodium—Purpura—Epirubicin—uterine cancer	0.00091	0.000997	CcSEcCtD
Fondaparinux sodium—Pain—Dactinomycin—uterine cancer	0.000909	0.000996	CcSEcCtD
Fondaparinux sodium—Vascular purpura—Doxorubicin—uterine cancer	0.000907	0.000994	CcSEcCtD
Fondaparinux sodium—Dizziness—Medroxyprogesterone Acetate—uterine cancer	0.000901	0.000987	CcSEcCtD
Fondaparinux sodium—Cardiac failure—Epirubicin—uterine cancer	0.000899	0.000985	CcSEcCtD
Fondaparinux sodium—Cerebrovascular accident—Epirubicin—uterine cancer	0.000895	0.000981	CcSEcCtD
Fondaparinux sodium—Cardiac failure congestive—Doxorubicin—uterine cancer	0.000895	0.000981	CcSEcCtD
Fondaparinux sodium—Nausea—Progesterone—uterine cancer	0.000893	0.000979	CcSEcCtD
Fondaparinux sodium—Renal failure acute—Doxorubicin—uterine cancer	0.000879	0.000963	CcSEcCtD
Fondaparinux sodium—Pain in extremity—Epirubicin—uterine cancer	0.000877	0.000961	CcSEcCtD
Fondaparinux sodium—Feeling abnormal—Dactinomycin—uterine cancer	0.000876	0.00096	CcSEcCtD
Fondaparinux sodium—Anaemia—Etoposide—uterine cancer	0.000871	0.000955	CcSEcCtD
Fondaparinux sodium—Gastrointestinal pain—Dactinomycin—uterine cancer	0.000869	0.000952	CcSEcCtD
Fondaparinux sodium—Hot flush—Doxorubicin—uterine cancer	0.000867	0.000951	CcSEcCtD
Fondaparinux sodium—Vomiting—Medroxyprogesterone Acetate—uterine cancer	0.000866	0.000949	CcSEcCtD
Fondaparinux sodium—Menopausal symptoms—Doxorubicin—uterine cancer	0.00086	0.000943	CcSEcCtD
Fondaparinux sodium—Rash—Medroxyprogesterone Acetate—uterine cancer	0.000859	0.000941	CcSEcCtD
Fondaparinux sodium—Dermatitis—Medroxyprogesterone Acetate—uterine cancer	0.000858	0.000941	CcSEcCtD
Fondaparinux sodium—Headache—Medroxyprogesterone Acetate—uterine cancer	0.000853	0.000935	CcSEcCtD
Fondaparinux sodium—Renal impairment—Doxorubicin—uterine cancer	0.000853	0.000935	CcSEcCtD
Fondaparinux sodium—Dermatitis bullous—Doxorubicin—uterine cancer	0.000849	0.000931	CcSEcCtD
Fondaparinux sodium—Vertigo—Etoposide—uterine cancer	0.000846	0.000928	CcSEcCtD
Fondaparinux sodium—Purpura—Doxorubicin—uterine cancer	0.000842	0.000923	CcSEcCtD
Fondaparinux sodium—Body temperature increased—Dactinomycin—uterine cancer	0.00084	0.000921	CcSEcCtD
Fondaparinux sodium—Abdominal pain—Dactinomycin—uterine cancer	0.00084	0.000921	CcSEcCtD
Fondaparinux sodium—Cardiac arrest—Epirubicin—uterine cancer	0.000834	0.000914	CcSEcCtD
Fondaparinux sodium—Cardiac failure—Doxorubicin—uterine cancer	0.000831	0.000911	CcSEcCtD
Fondaparinux sodium—Loss of consciousness—Etoposide—uterine cancer	0.000828	0.000908	CcSEcCtD
Fondaparinux sodium—Cerebrovascular accident—Doxorubicin—uterine cancer	0.000828	0.000908	CcSEcCtD
Fondaparinux sodium—Cough—Etoposide—uterine cancer	0.000822	0.000901	CcSEcCtD
Fondaparinux sodium—Blood creatinine increased—Epirubicin—uterine cancer	0.000822	0.000901	CcSEcCtD
Fondaparinux sodium—Convulsion—Etoposide—uterine cancer	0.000816	0.000895	CcSEcCtD
Fondaparinux sodium—Dehydration—Epirubicin—uterine cancer	0.000816	0.000894	CcSEcCtD
Fondaparinux sodium—Pain in extremity—Doxorubicin—uterine cancer	0.000811	0.00089	CcSEcCtD
Fondaparinux sodium—Nausea—Medroxyprogesterone Acetate—uterine cancer	0.000809	0.000887	CcSEcCtD
Fondaparinux sodium—Chest pain—Etoposide—uterine cancer	0.000802	0.000879	CcSEcCtD
Fondaparinux sodium—Hypokalaemia—Epirubicin—uterine cancer	0.000798	0.000875	CcSEcCtD
Fondaparinux sodium—Unspecified disorder of skin and subcutaneous tissue—Etoposide—uterine cancer	0.000797	0.000873	CcSEcCtD
Fondaparinux sodium—Aspartate aminotransferase increased—Epirubicin—uterine cancer	0.00079	0.000866	CcSEcCtD
Fondaparinux sodium—Hypersensitivity—Dactinomycin—uterine cancer	0.000783	0.000858	CcSEcCtD
Fondaparinux sodium—Gastritis—Epirubicin—uterine cancer	0.000776	0.000851	CcSEcCtD
Fondaparinux sodium—Confusional state—Etoposide—uterine cancer	0.000775	0.00085	CcSEcCtD
Fondaparinux sodium—Alanine aminotransferase increased—Epirubicin—uterine cancer	0.000773	0.000848	CcSEcCtD
Fondaparinux sodium—Cardiac arrest—Doxorubicin—uterine cancer	0.000772	0.000846	CcSEcCtD
Fondaparinux sodium—Anaphylactic shock—Etoposide—uterine cancer	0.000769	0.000843	CcSEcCtD
Fondaparinux sodium—Infection—Etoposide—uterine cancer	0.000764	0.000837	CcSEcCtD
Fondaparinux sodium—Abdominal distension—Epirubicin—uterine cancer	0.000763	0.000836	CcSEcCtD
Fondaparinux sodium—Asthenia—Dactinomycin—uterine cancer	0.000762	0.000836	CcSEcCtD
Fondaparinux sodium—Blood creatinine increased—Doxorubicin—uterine cancer	0.00076	0.000833	CcSEcCtD
Fondaparinux sodium—Dysphagia—Epirubicin—uterine cancer	0.000758	0.000831	CcSEcCtD
Fondaparinux sodium—Dehydration—Doxorubicin—uterine cancer	0.000755	0.000827	CcSEcCtD
Fondaparinux sodium—Thrombocytopenia—Etoposide—uterine cancer	0.000753	0.000825	CcSEcCtD
Fondaparinux sodium—Tachycardia—Etoposide—uterine cancer	0.00075	0.000823	CcSEcCtD
Fondaparinux sodium—Skin disorder—Etoposide—uterine cancer	0.000747	0.000819	CcSEcCtD
Fondaparinux sodium—Hyperhidrosis—Etoposide—uterine cancer	0.000743	0.000815	CcSEcCtD
Fondaparinux sodium—Hypokalaemia—Doxorubicin—uterine cancer	0.000738	0.00081	CcSEcCtD
Fondaparinux sodium—Anorexia—Etoposide—uterine cancer	0.000733	0.000804	CcSEcCtD
Fondaparinux sodium—Aspartate aminotransferase increased—Doxorubicin—uterine cancer	0.000731	0.000801	CcSEcCtD
Fondaparinux sodium—Bronchitis—Epirubicin—uterine cancer	0.000729	0.000799	CcSEcCtD
Fondaparinux sodium—Diarrhoea—Dactinomycin—uterine cancer	0.000727	0.000797	CcSEcCtD
Fondaparinux sodium—Hypotension—Etoposide—uterine cancer	0.000719	0.000788	CcSEcCtD
Fondaparinux sodium—Gastritis—Doxorubicin—uterine cancer	0.000718	0.000787	CcSEcCtD
Fondaparinux sodium—Alanine aminotransferase increased—Doxorubicin—uterine cancer	0.000716	0.000785	CcSEcCtD
Fondaparinux sodium—Abdominal distension—Doxorubicin—uterine cancer	0.000706	0.000774	CcSEcCtD
Fondaparinux sodium—Dysphagia—Doxorubicin—uterine cancer	0.000701	0.000769	CcSEcCtD
Fondaparinux sodium—Paraesthesia—Etoposide—uterine cancer	0.00069	0.000757	CcSEcCtD
Fondaparinux sodium—Dyspnoea—Etoposide—uterine cancer	0.000686	0.000752	CcSEcCtD
Fondaparinux sodium—Somnolence—Etoposide—uterine cancer	0.000684	0.000749	CcSEcCtD
Fondaparinux sodium—Infestation NOS—Epirubicin—uterine cancer	0.000676	0.000741	CcSEcCtD
Fondaparinux sodium—Infestation—Epirubicin—uterine cancer	0.000676	0.000741	CcSEcCtD
Fondaparinux sodium—Vomiting—Dactinomycin—uterine cancer	0.000676	0.000741	CcSEcCtD
Fondaparinux sodium—Bronchitis—Doxorubicin—uterine cancer	0.000674	0.000739	CcSEcCtD
Fondaparinux sodium—Rash—Dactinomycin—uterine cancer	0.00067	0.000734	CcSEcCtD
Fondaparinux sodium—Decreased appetite—Etoposide—uterine cancer	0.000668	0.000733	CcSEcCtD
Fondaparinux sodium—Renal failure—Epirubicin—uterine cancer	0.000664	0.000728	CcSEcCtD
Fondaparinux sodium—Gastrointestinal disorder—Etoposide—uterine cancer	0.000664	0.000728	CcSEcCtD
Fondaparinux sodium—Fatigue—Etoposide—uterine cancer	0.000663	0.000727	CcSEcCtD
Fondaparinux sodium—Constipation—Etoposide—uterine cancer	0.000658	0.000721	CcSEcCtD
Fondaparinux sodium—Pain—Etoposide—uterine cancer	0.000658	0.000721	CcSEcCtD
Fondaparinux sodium—Urinary tract infection—Epirubicin—uterine cancer	0.000657	0.00072	CcSEcCtD
Fondaparinux sodium—Haematuria—Epirubicin—uterine cancer	0.000644	0.000706	CcSEcCtD
Fondaparinux sodium—Hepatobiliary disease—Epirubicin—uterine cancer	0.000639	0.000701	CcSEcCtD
Fondaparinux sodium—Epistaxis—Epirubicin—uterine cancer	0.000637	0.000699	CcSEcCtD
Fondaparinux sodium—Feeling abnormal—Etoposide—uterine cancer	0.000634	0.000695	CcSEcCtD
Fondaparinux sodium—Nausea—Dactinomycin—uterine cancer	0.000631	0.000692	CcSEcCtD
Fondaparinux sodium—Gastrointestinal pain—Etoposide—uterine cancer	0.000629	0.000689	CcSEcCtD
Fondaparinux sodium—Infestation NOS—Doxorubicin—uterine cancer	0.000625	0.000686	CcSEcCtD
Fondaparinux sodium—Infestation—Doxorubicin—uterine cancer	0.000625	0.000686	CcSEcCtD
Fondaparinux sodium—Renal failure—Doxorubicin—uterine cancer	0.000615	0.000674	CcSEcCtD
Fondaparinux sodium—Urticaria—Etoposide—uterine cancer	0.000611	0.00067	CcSEcCtD
Fondaparinux sodium—Haemoglobin—Epirubicin—uterine cancer	0.00061	0.000668	CcSEcCtD
Fondaparinux sodium—Body temperature increased—Etoposide—uterine cancer	0.000608	0.000666	CcSEcCtD
Fondaparinux sodium—Abdominal pain—Etoposide—uterine cancer	0.000608	0.000666	CcSEcCtD
Fondaparinux sodium—Urinary tract infection—Doxorubicin—uterine cancer	0.000608	0.000666	CcSEcCtD
Fondaparinux sodium—Haemorrhage—Epirubicin—uterine cancer	0.000607	0.000665	CcSEcCtD
Fondaparinux sodium—Hypoaesthesia—Epirubicin—uterine cancer	0.000604	0.000662	CcSEcCtD
Fondaparinux sodium—Oedema peripheral—Epirubicin—uterine cancer	0.000598	0.000655	CcSEcCtD
Fondaparinux sodium—Haematuria—Doxorubicin—uterine cancer	0.000596	0.000654	CcSEcCtD
Fondaparinux sodium—Hepatobiliary disease—Doxorubicin—uterine cancer	0.000591	0.000648	CcSEcCtD
Fondaparinux sodium—Epistaxis—Doxorubicin—uterine cancer	0.00059	0.000647	CcSEcCtD
Fondaparinux sodium—Hypersensitivity—Etoposide—uterine cancer	0.000567	0.000621	CcSEcCtD
Fondaparinux sodium—Haemoglobin—Doxorubicin—uterine cancer	0.000564	0.000619	CcSEcCtD
Fondaparinux sodium—Flushing—Epirubicin—uterine cancer	0.000563	0.000617	CcSEcCtD
Fondaparinux sodium—Haemorrhage—Doxorubicin—uterine cancer	0.000561	0.000615	CcSEcCtD
Fondaparinux sodium—Hypoaesthesia—Doxorubicin—uterine cancer	0.000559	0.000612	CcSEcCtD
Fondaparinux sodium—Oedema peripheral—Doxorubicin—uterine cancer	0.000553	0.000606	CcSEcCtD
Fondaparinux sodium—Asthenia—Etoposide—uterine cancer	0.000552	0.000605	CcSEcCtD
Fondaparinux sodium—Angiopathy—Epirubicin—uterine cancer	0.00055	0.000603	CcSEcCtD
Fondaparinux sodium—Immune system disorder—Epirubicin—uterine cancer	0.000548	0.000601	CcSEcCtD
Fondaparinux sodium—Mediastinal disorder—Epirubicin—uterine cancer	0.000547	0.000599	CcSEcCtD
Fondaparinux sodium—Pruritus—Etoposide—uterine cancer	0.000544	0.000596	CcSEcCtD
Fondaparinux sodium—Arrhythmia—Epirubicin—uterine cancer	0.000542	0.000594	CcSEcCtD
Fondaparinux sodium—Malnutrition—Epirubicin—uterine cancer	0.000528	0.000579	CcSEcCtD
Fondaparinux sodium—Diarrhoea—Etoposide—uterine cancer	0.000526	0.000577	CcSEcCtD
Fondaparinux sodium—Flushing—Doxorubicin—uterine cancer	0.000521	0.000571	CcSEcCtD
Fondaparinux sodium—Flatulence—Epirubicin—uterine cancer	0.00052	0.000571	CcSEcCtD
Fondaparinux sodium—Dysgeusia—Epirubicin—uterine cancer	0.000517	0.000567	CcSEcCtD
Fondaparinux sodium—Back pain—Epirubicin—uterine cancer	0.000511	0.00056	CcSEcCtD
Fondaparinux sodium—Angiopathy—Doxorubicin—uterine cancer	0.000509	0.000558	CcSEcCtD
Fondaparinux sodium—Dizziness—Etoposide—uterine cancer	0.000508	0.000557	CcSEcCtD
Fondaparinux sodium—Immune system disorder—Doxorubicin—uterine cancer	0.000507	0.000556	CcSEcCtD
Fondaparinux sodium—Mediastinal disorder—Doxorubicin—uterine cancer	0.000506	0.000555	CcSEcCtD
Fondaparinux sodium—Arrhythmia—Doxorubicin—uterine cancer	0.000501	0.00055	CcSEcCtD
Fondaparinux sodium—Vision blurred—Epirubicin—uterine cancer	0.000498	0.000546	CcSEcCtD
Fondaparinux sodium—Vomiting—Etoposide—uterine cancer	0.000489	0.000536	CcSEcCtD
Fondaparinux sodium—Malnutrition—Doxorubicin—uterine cancer	0.000489	0.000536	CcSEcCtD
Fondaparinux sodium—Anaemia—Epirubicin—uterine cancer	0.000488	0.000535	CcSEcCtD
Fondaparinux sodium—Rash—Etoposide—uterine cancer	0.000485	0.000531	CcSEcCtD
Fondaparinux sodium—Dermatitis—Etoposide—uterine cancer	0.000484	0.000531	CcSEcCtD
Fondaparinux sodium—Headache—Etoposide—uterine cancer	0.000482	0.000528	CcSEcCtD
Fondaparinux sodium—Flatulence—Doxorubicin—uterine cancer	0.000482	0.000528	CcSEcCtD
Fondaparinux sodium—Dysgeusia—Doxorubicin—uterine cancer	0.000479	0.000525	CcSEcCtD
Fondaparinux sodium—Vertigo—Epirubicin—uterine cancer	0.000474	0.00052	CcSEcCtD
Fondaparinux sodium—Syncope—Epirubicin—uterine cancer	0.000474	0.000519	CcSEcCtD
Fondaparinux sodium—Back pain—Doxorubicin—uterine cancer	0.000473	0.000518	CcSEcCtD
Fondaparinux sodium—Palpitations—Epirubicin—uterine cancer	0.000467	0.000512	CcSEcCtD
Fondaparinux sodium—Loss of consciousness—Epirubicin—uterine cancer	0.000464	0.000509	CcSEcCtD
Fondaparinux sodium—Cough—Epirubicin—uterine cancer	0.000461	0.000505	CcSEcCtD
Fondaparinux sodium—Vision blurred—Doxorubicin—uterine cancer	0.000461	0.000505	CcSEcCtD
Fondaparinux sodium—Convulsion—Epirubicin—uterine cancer	0.000458	0.000502	CcSEcCtD
Fondaparinux sodium—Nausea—Etoposide—uterine cancer	0.000457	0.000501	CcSEcCtD
Fondaparinux sodium—Anaemia—Doxorubicin—uterine cancer	0.000452	0.000495	CcSEcCtD
Fondaparinux sodium—Chest pain—Epirubicin—uterine cancer	0.00045	0.000493	CcSEcCtD
Fondaparinux sodium—Anxiety—Epirubicin—uterine cancer	0.000448	0.000491	CcSEcCtD
Fondaparinux sodium—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—uterine cancer	0.000447	0.00049	CcSEcCtD
Fondaparinux sodium—Vertigo—Doxorubicin—uterine cancer	0.000439	0.000481	CcSEcCtD
Fondaparinux sodium—Syncope—Doxorubicin—uterine cancer	0.000438	0.00048	CcSEcCtD
Fondaparinux sodium—Confusional state—Epirubicin—uterine cancer	0.000435	0.000476	CcSEcCtD
Fondaparinux sodium—Palpitations—Doxorubicin—uterine cancer	0.000432	0.000473	CcSEcCtD
Fondaparinux sodium—Oedema—Epirubicin—uterine cancer	0.000431	0.000473	CcSEcCtD
Fondaparinux sodium—Anaphylactic shock—Epirubicin—uterine cancer	0.000431	0.000473	CcSEcCtD
Fondaparinux sodium—Loss of consciousness—Doxorubicin—uterine cancer	0.00043	0.000471	CcSEcCtD
Fondaparinux sodium—Infection—Epirubicin—uterine cancer	0.000428	0.000469	CcSEcCtD
Fondaparinux sodium—Cough—Doxorubicin—uterine cancer	0.000426	0.000467	CcSEcCtD
Fondaparinux sodium—Shock—Epirubicin—uterine cancer	0.000424	0.000465	CcSEcCtD
Fondaparinux sodium—Convulsion—Doxorubicin—uterine cancer	0.000423	0.000464	CcSEcCtD
Fondaparinux sodium—Nervous system disorder—Epirubicin—uterine cancer	0.000423	0.000463	CcSEcCtD
Fondaparinux sodium—Thrombocytopenia—Epirubicin—uterine cancer	0.000422	0.000463	CcSEcCtD
Fondaparinux sodium—Tachycardia—Epirubicin—uterine cancer	0.000421	0.000461	CcSEcCtD
Fondaparinux sodium—Skin disorder—Epirubicin—uterine cancer	0.000419	0.000459	CcSEcCtD
Fondaparinux sodium—Hyperhidrosis—Epirubicin—uterine cancer	0.000417	0.000457	CcSEcCtD
Fondaparinux sodium—Chest pain—Doxorubicin—uterine cancer	0.000416	0.000456	CcSEcCtD
Fondaparinux sodium—Anxiety—Doxorubicin—uterine cancer	0.000415	0.000454	CcSEcCtD
Fondaparinux sodium—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—uterine cancer	0.000413	0.000453	CcSEcCtD
Fondaparinux sodium—Anorexia—Epirubicin—uterine cancer	0.000411	0.00045	CcSEcCtD
Fondaparinux sodium—Hypotension—Epirubicin—uterine cancer	0.000403	0.000442	CcSEcCtD
Fondaparinux sodium—Confusional state—Doxorubicin—uterine cancer	0.000402	0.000441	CcSEcCtD
Fondaparinux sodium—Anaphylactic shock—Doxorubicin—uterine cancer	0.000399	0.000437	CcSEcCtD
Fondaparinux sodium—Oedema—Doxorubicin—uterine cancer	0.000399	0.000437	CcSEcCtD
Fondaparinux sodium—Infection—Doxorubicin—uterine cancer	0.000396	0.000434	CcSEcCtD
Fondaparinux sodium—Shock—Doxorubicin—uterine cancer	0.000392	0.00043	CcSEcCtD
Fondaparinux sodium—Nervous system disorder—Doxorubicin—uterine cancer	0.000391	0.000429	CcSEcCtD
Fondaparinux sodium—Thrombocytopenia—Doxorubicin—uterine cancer	0.00039	0.000428	CcSEcCtD
Fondaparinux sodium—Insomnia—Epirubicin—uterine cancer	0.00039	0.000427	CcSEcCtD
Fondaparinux sodium—Tachycardia—Doxorubicin—uterine cancer	0.000389	0.000427	CcSEcCtD
Fondaparinux sodium—Skin disorder—Doxorubicin—uterine cancer	0.000387	0.000425	CcSEcCtD
Fondaparinux sodium—Paraesthesia—Epirubicin—uterine cancer	0.000387	0.000424	CcSEcCtD
Fondaparinux sodium—Hyperhidrosis—Doxorubicin—uterine cancer	0.000386	0.000423	CcSEcCtD
Fondaparinux sodium—Dyspnoea—Epirubicin—uterine cancer	0.000384	0.000421	CcSEcCtD
Fondaparinux sodium—Somnolence—Epirubicin—uterine cancer	0.000383	0.00042	CcSEcCtD
Fondaparinux sodium—Anorexia—Doxorubicin—uterine cancer	0.00038	0.000417	CcSEcCtD
Fondaparinux sodium—Dyspepsia—Epirubicin—uterine cancer	0.000379	0.000416	CcSEcCtD
Fondaparinux sodium—Decreased appetite—Epirubicin—uterine cancer	0.000375	0.000411	CcSEcCtD
Fondaparinux sodium—Hypotension—Doxorubicin—uterine cancer	0.000373	0.000409	CcSEcCtD
Fondaparinux sodium—Gastrointestinal disorder—Epirubicin—uterine cancer	0.000372	0.000408	CcSEcCtD
Fondaparinux sodium—Fatigue—Epirubicin—uterine cancer	0.000372	0.000407	CcSEcCtD
Fondaparinux sodium—Pain—Epirubicin—uterine cancer	0.000369	0.000404	CcSEcCtD
Fondaparinux sodium—Constipation—Epirubicin—uterine cancer	0.000369	0.000404	CcSEcCtD
Fondaparinux sodium—Insomnia—Doxorubicin—uterine cancer	0.000361	0.000395	CcSEcCtD
Fondaparinux sodium—Paraesthesia—Doxorubicin—uterine cancer	0.000358	0.000393	CcSEcCtD
Fondaparinux sodium—Dyspnoea—Doxorubicin—uterine cancer	0.000356	0.00039	CcSEcCtD
Fondaparinux sodium—Feeling abnormal—Epirubicin—uterine cancer	0.000355	0.000389	CcSEcCtD
Fondaparinux sodium—Somnolence—Doxorubicin—uterine cancer	0.000355	0.000389	CcSEcCtD
Fondaparinux sodium—Gastrointestinal pain—Epirubicin—uterine cancer	0.000352	0.000386	CcSEcCtD
Fondaparinux sodium—Dyspepsia—Doxorubicin—uterine cancer	0.000351	0.000385	CcSEcCtD
Fondaparinux sodium—Decreased appetite—Doxorubicin—uterine cancer	0.000347	0.00038	CcSEcCtD
Fondaparinux sodium—Gastrointestinal disorder—Doxorubicin—uterine cancer	0.000344	0.000377	CcSEcCtD
Fondaparinux sodium—Fatigue—Doxorubicin—uterine cancer	0.000344	0.000377	CcSEcCtD
Fondaparinux sodium—Urticaria—Epirubicin—uterine cancer	0.000342	0.000375	CcSEcCtD
Fondaparinux sodium—Pain—Doxorubicin—uterine cancer	0.000341	0.000374	CcSEcCtD
Fondaparinux sodium—Constipation—Doxorubicin—uterine cancer	0.000341	0.000374	CcSEcCtD
Fondaparinux sodium—Abdominal pain—Epirubicin—uterine cancer	0.000341	0.000374	CcSEcCtD
Fondaparinux sodium—Body temperature increased—Epirubicin—uterine cancer	0.000341	0.000374	CcSEcCtD
Fondaparinux sodium—Feeling abnormal—Doxorubicin—uterine cancer	0.000329	0.00036	CcSEcCtD
Fondaparinux sodium—Gastrointestinal pain—Doxorubicin—uterine cancer	0.000326	0.000358	CcSEcCtD
Fondaparinux sodium—Hypersensitivity—Epirubicin—uterine cancer	0.000318	0.000348	CcSEcCtD
Fondaparinux sodium—Urticaria—Doxorubicin—uterine cancer	0.000317	0.000347	CcSEcCtD
Fondaparinux sodium—Body temperature increased—Doxorubicin—uterine cancer	0.000315	0.000346	CcSEcCtD
Fondaparinux sodium—Abdominal pain—Doxorubicin—uterine cancer	0.000315	0.000346	CcSEcCtD
Fondaparinux sodium—Asthenia—Epirubicin—uterine cancer	0.000309	0.000339	CcSEcCtD
Fondaparinux sodium—Pruritus—Epirubicin—uterine cancer	0.000305	0.000334	CcSEcCtD
Fondaparinux sodium—Diarrhoea—Epirubicin—uterine cancer	0.000295	0.000323	CcSEcCtD
Fondaparinux sodium—Hypersensitivity—Doxorubicin—uterine cancer	0.000294	0.000322	CcSEcCtD
Fondaparinux sodium—Asthenia—Doxorubicin—uterine cancer	0.000286	0.000314	CcSEcCtD
Fondaparinux sodium—Dizziness—Epirubicin—uterine cancer	0.000285	0.000312	CcSEcCtD
Fondaparinux sodium—Pruritus—Doxorubicin—uterine cancer	0.000282	0.000309	CcSEcCtD
Fondaparinux sodium—Vomiting—Epirubicin—uterine cancer	0.000274	0.0003	CcSEcCtD
Fondaparinux sodium—Diarrhoea—Doxorubicin—uterine cancer	0.000273	0.000299	CcSEcCtD
Fondaparinux sodium—Rash—Epirubicin—uterine cancer	0.000272	0.000298	CcSEcCtD
Fondaparinux sodium—Dermatitis—Epirubicin—uterine cancer	0.000272	0.000298	CcSEcCtD
Fondaparinux sodium—Headache—Epirubicin—uterine cancer	0.00027	0.000296	CcSEcCtD
Fondaparinux sodium—Dizziness—Doxorubicin—uterine cancer	0.000264	0.000289	CcSEcCtD
Fondaparinux sodium—Nausea—Epirubicin—uterine cancer	0.000256	0.000281	CcSEcCtD
Fondaparinux sodium—Vomiting—Doxorubicin—uterine cancer	0.000254	0.000278	CcSEcCtD
Fondaparinux sodium—Rash—Doxorubicin—uterine cancer	0.000251	0.000276	CcSEcCtD
Fondaparinux sodium—Dermatitis—Doxorubicin—uterine cancer	0.000251	0.000275	CcSEcCtD
Fondaparinux sodium—Headache—Doxorubicin—uterine cancer	0.00025	0.000274	CcSEcCtD
Fondaparinux sodium—Nausea—Doxorubicin—uterine cancer	0.000237	0.00026	CcSEcCtD
